FDA
-
-
-
-
-
-
-
Zymeworks Appoints Suzanne Monahan as Senior Vice President, Commercial and General Manager, Theravance Biopharma
-
-
-
-
-
-
-
Zymeworks to buy Theravance Biopharma for $17 per share
-
-
-
-
-
-
-
Zymeworks Provides Corporate Update and Reports First Quarter 2026 Financial Results
-
-
-
-
-
-
-
Zymeworks names new R&D head and chief business officer
-
-
-
-
-
-
-
Zymeworks to present clinical data on cancer drug candidates at AACR
-
-
-
-
-
-
-
Zymeworks Announces Leadership Appointments and Transitions to Align with Evolution of Corporate Strategy
-
-
-
-
-
-
-
Zymeworks Appoints Scott Platshon as Acting Chief Investment Officer
-
335,347 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


